Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552561 | PMC |
http://dx.doi.org/10.3389/fonc.2023.1285031 | DOI Listing |
J Neurol
January 2025
Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Objectives: To report myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) epidemiology in two American regions using 2023 diagnostic criteria.
Patients And Methods: We compared age- and sex-adjusted incidence and prevalence of MOGAD per 2023 diagnostic criteria in Olmsted County (Minnesota [USA]) and Martinique (Caribbean [FR]) (01/01/2003-12/31/2018, prevalence day) using Poisson regression. Archived sera in 68-85% were available for MOG-IgG testing by live cell-based assay at Mayo Clinic.
Indian J Gastroenterol
January 2025
Asian Institute of Gastroenterology, Hyderabad, 500 082, India.
Indian J Gastroenterol
January 2025
Department of Gastroenterology and Hepatology, Kalinga Institute of Medical Sciences, Patia, Bhubaneswar, 751 024, India.
Indian J Gastroenterol
January 2025
Department of Radiodiagnosis and Interventional Radiology, All India Institute of Medical Sciences, Sri Aurobindo Marg, Ansari Nagar, Ansari Nagar East, New Delhi, 110 029, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!